These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19608600)

  • 41. A generalized semiparametric mixed model for analysis of multivariate health care utilization data.
    Li Z; Liu H; Tu W
    Stat Methods Med Res; 2017 Dec; 26(6):2909-2918. PubMed ID: 26596349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generalized linear latent variable models for repeated measures of spatially correlated multivariate data.
    Zhu J; Eickhoff JC; Yan P
    Biometrics; 2005 Sep; 61(3):674-83. PubMed ID: 16135018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imputation-based strategies for clinical trial longitudinal data with nonignorable missing values.
    Yang X; Li J; Shoptaw S
    Stat Med; 2008 Jul; 27(15):2826-49. PubMed ID: 18205247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bayesian mixed-effects location and scale models for multivariate longitudinal outcomes: an application to ecological momentary assessment data.
    Kapur K; Li X; Blood EA; Hedeker D
    Stat Med; 2015 Feb; 34(4):630-51. PubMed ID: 25409923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A joint model for nonlinear longitudinal data with informative dropout.
    Hu C; Sale ME
    J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):83-103. PubMed ID: 12800808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing for treatment differences with dropouts present in clinical trials--a composite approach.
    Shih WJ; Quan H
    Stat Med; 1997 Jun; 16(11):1225-39. PubMed ID: 9194269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Causal inference from longitudinal studies with baseline randomization.
    Toh S; Hernán MA
    Int J Biostat; 2008 Oct; 4(1):Article 22. PubMed ID: 20231914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings.
    Donneau AF; Mauer M; Lambert P; Molenberghs G; Albert A
    J Biopharm Stat; 2015; 25(3):570-601. PubMed ID: 24905056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A random-effects mixture model for classifying treatment response in longitudinal clinical trials.
    Xu W; Hedeker D
    J Biopharm Stat; 2001 Nov; 11(4):253-73. PubMed ID: 12018779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous comparisons of treatments at multiple time points: Combined marginal models versus joint modeling.
    Pallmann P; Pretorius M; Ritz C
    Stat Methods Med Res; 2017 Dec; 26(6):2633-2648. PubMed ID: 26384515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the appropriateness of marginal models for repeated measurements in clinical trials.
    Lindsey JK; Lambert P
    Stat Med; 1998 Feb; 17(4):447-69. PubMed ID: 9496722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of multivariate mixed longitudinal data: a flexible latent process approach.
    Proust-Lima C; Amieva H; Jacqmin-Gadda H
    Br J Math Stat Psychol; 2013 Nov; 66(3):470-87. PubMed ID: 23082854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Compliance and attrition in the longitudinal surveys in Africa].
    Chippaux JP
    Bull Soc Pathol Exot; 2004 Nov; 97(4):257-60. PubMed ID: 17304746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed.
    Daniel RM; Tsiatis AA
    Lifetime Data Anal; 2013 Oct; 19(4):513-46. PubMed ID: 23722304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A monotone data augmentation algorithm for multivariate nonnormal data: With applications to controlled imputations for longitudinal trials.
    Tang Y
    Stat Med; 2019 May; 38(10):1715-1733. PubMed ID: 30565281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline patient characteristics and mortality associated with longitudinal intervention compliance.
    Lin JY; Ten Have TR; Bogner HR; Elliott MR
    Stat Med; 2007 Dec; 26(28):5100-15. PubMed ID: 17477334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation.
    Ahn JE; French JL
    J Pharmacokinet Pharmacodyn; 2010 Apr; 37(2):179-201. PubMed ID: 20358280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal data analysis (repeated measures) in clinical trials.
    Albert PS
    Stat Med; 1999 Jul; 18(13):1707-32. PubMed ID: 10407239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.